SCHEMBL8289181

SCHEMBL8289181

Bc1ccc(CN)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15828 0.83 HRH3 (0.79) —
Hydrochloric Acid SCHEMBL3162690 0.79 HRH3 (0.73) —
Iodide SCHEMBL29191162 0.79 HRH3 (0.73) —
Bromide SCHEMBL29198706 0.79 HRH3 (0.73) —
Iodide SCHEMBL28395414 0.79 HRH3 (0.73) —
Hydrochloric Acid SCHEMBL3168189 0.79 HRH3 (0.73) —
SCHEMBL8251234 0.77 TAAR1 (0.56) —
Benzene SCHEMBL734439 0.76 LOXL2 (0.80) —
SCHEMBL6314683 0.73 HRH3 (0.65) —
Methyl Alcohol SCHEMBL22528993 0.73 ABAT (0.67) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807644-B2 Methods and compounds for restoring mutant p53 function PMV PHARMACEUTICALS, INC. (US) 2023-11-07 — — US disclosed
US-11807644-B2 Methods and compounds for restoring mutant p53 function PMV PHARMACEUTICALS, INC. (US) 2023-11-07 — — US disclosed
US-20230002403-A1 METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION PMV PHARMACEUTICALS, INC. 2023-01-05 — — US disclosed
WO-2021231474-A1 METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION PMV PHARMACEUTICALS, INC. (US) 2021-11-18 — — WO disclosed
CN-106146567-B Organometallic compound and organic electroluminescent device comprising the same 财团法人工业技术研究院 2019-10-01 — — CN disclosed
CN-110072981-A Automobile gear lubricant oil composite 三井化学株式会社 2019-07-30 — — CN disclosed
CN-107624112-A Small molecule inhibitors of lactate dehydrogenase and methods of use thereof 美国政府健康及人类服务部 2018-01-23 — — CN disclosed
CN-106795449-A Lubricant oil composite 三井化学株式会社 2017-05-31 — — CN disclosed
US-9573942-B2 HIV inhibiting 5-amido substituted pyrimidines JANSSEN SCIENCES IRELAND UC (IE) 2017-02-21 — — US disclosed
CN-106133006-A Ethylene/alpha olefin polymer and lubricating oil 三井化学株式会社 2016-11-16 — — CN disclosed
US-20090309070-A1 COMPOSITIONS FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE MITSUBISHI CHEMICAL CORPORATION (JP) 2009-12-17 — — US disclosed
WO-2009052078-A1 CCR10 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 — — WO disclosed
US-20090033208-A1 FILM FORMING COMPOSITION AND ORGANIC ELECTROLUMINESCENT DEVICE PIONEER CORPORATION (JP) 2009-02-05 — — US disclosed
WO-2007064749-A1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND MICROBIAL DISEASES SCHERING CORPORATION (US) 2007-06-07 — — WO disclosed
US-20060178366-A1 Compounds for the treatment of inflammatory disorders SCHERING CORPORATION 2006-08-10 — — US disclosed
WO-2005058298-A2 FK228 ANALOGS AND THEIR USE AS HDAC-INHIBITORS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2005-06-30 — — WO disclosed
CN-1204126-C Process for preparing pyridazin-2-one derivs. SUMITOMO CHEMICAL CO (JP) 2005-06-01 — — CN disclosed
CN-1334805-A Process for preparing pyridazin-2-one derivs. SUMITOMO CHEMICAL CO (JP) 2002-02-06 — — CN disclosed
CN-1208050-A Olefin thermoplastic elastomer composition MITSUI CHEMICALS INC (JP) 1999-02-17 — — CN disclosed
EP-0199260-A2 Boronic acid adducts of technetium-99M dioxime complexes E.R. Squibb &amp; Sons, Inc. (US) 1986-10-29 — — EP disclosed
Send feedback